5,8,13,13a-四氢-9,10-二甲氧基-6H-苯并[g]苯并-1,3-二氧并[5,6-a]喹嗪

5,8,13,13a-四氢-9,10-二甲氧基-6H-苯并[g]苯并-1,3-二氧并[5,6-a]喹嗪（CAS 29074-38-2）的公开数据库记录，列此仅供独立核对。

危险化学品分类与危害说明

法规与备案状态

物理形态与操作说明

• 2.1 [ug/mL] (The mean of the results at pH 7.4)

这个物质在各数据库里的编号

数据库记载的用途

• Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
• A class of drugs that act by selective inhibition of calcium influx through cellular membranes.
• Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.

它在各数据库里的别名

Canadine; 522-97-4; Xanthopuccine; Canadin; dl-Tetrahydroberberine; DTXSID5022724; V2SSH085X8; 9,10-Dimethoxy-2,3-(methylenedioxy)berbine; NSC-36351; NSC-94918; DTXCID802724; 16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene; CHEBI:22998; 5,8,13,13a-tetrahydro-9,10-dimethoxy-6H-benzo(g)-1,3-benzodioxolo(5,6-a)quinolizine; (+-)-Tetrahydroberberine; 16,17-dimethoxy-5,7-dioxa-13-azapentacyclo(11.8.0.02,10.04,8.015,20)henicosa-2,4(8),9,15(20),16,18-hexaene

计算机算出的分子描述符

数据库摘要

5,8,13,13a-tetrahydro-9,10-dimethoxy-6H-benzo[g]benzo-1,3-dioxolo[5,6-a]quinolizine · CAS 29074-38-2 · C20H21NO4. UNII V2SSH085X8.

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。